FDA Approved: LACOSAMIDE — Original Application (ScieGen Pharmaceuticals Inc)

View source ↗

Summary

FDA approved ScieGen Pharmaceuticals Inc's lacosamide generic under an Original Application (ANDA205237) for marketing in epilepsy patients. Lacosamide is indic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• Lacosamide (Lacosamide)

Snippet

ORIG AP for LACOSAMIDE (LACOSAMIDE)